Bortezomib Glenmark contains bortezomib and is used to treat cancers like multiple myeloma (a bone marrow cancer) and mantle cell lymphoma (a type of lymph node cancer) by destroying cancer cells.
Your doctor will decide your dose based on your height and weight; the usual starting dose is 1.3 mg per square meter of body surface area twice a week.
The medicine is given as an injection into a vein (as a quick shot) or under the skin (into the thigh or stomach). A healthcare professional will administer the medicine.
The medicine is usually given twice a week and is not taken daily.